Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03051659
Brief Title: A Randomized Phase II Study Of Eribulin Mesylate With or Without Pembrolizumab For Metastatic Hormone Receptor Positive Breast Cancer

First Submitted : February 8, 2017
First Submitted that Met QC Criteria : February 9, 2017
First Posted : February 14, 2017

Last Update Submitted that Met QC Criteria : April 25, 2020
Last Update Posted : April 28, 2020